TCIM
OPTR

TIAA CREF Investment Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

TIAA CREF Investment Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-220,089
Closed -$2.77M – 3159
2013
Q3 		$2.77M Sell
220,089
-4,625
-2% -$61.3K ﹤0.01% 2003
2013
Q2 		$3.25M Buy
+224,714
New +$3.27M ﹤0.01% 1836

TIAA CREF Investment Management's OPTR Position: Q4 2013 in Review

TIAA CREF Investment Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 220,089 shares — an estimated $2.77M sold.

TIAA CREF Investment Management first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $3.25M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • TIAA CREF Investment Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • TIAA CREF Investment Management sold 220,089 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2.77M.
  • TIAA CREF Investment Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • TIAA CREF Investment Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $3.25M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on TIAA CREF Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.